Industry & Commerce

Tackling diseases through the Net

Wednesday, September 16, 2015 - 12:52

Monitoring health on a large scale through Big Data or using social networks to modify behaviour and risk factors are two relevant examples of how cutting edge technology may provide new and powerful tools against infectious diseases.

Many public and private agencies and bodies gather data from social networks and search engines to try and identify health emergencies and solve the problem: the most common approach is to analyze the search strings used by Google and the texts of blogs, forums and other pages on the Net.

Target: 
Decision Makers, Government and Public Health, Industry & Commerce
Topic: 
Epidemiology, Social Media
Tags: 
Social media, technology

Guidance for Industry – Internet/Social Media Platforms: Correcting Independent Third-Party Misinformation About Prescription Drugs and Medical Devices

Food and Drug Administration(FDA). 2014. Guidance for Industry – Internet/Social Media Platforms: Correcting Independent Third-Party Misinformation About Prescription Drugs and Medical Devices.

Target: 
Industry & Commerce
Topic: 
Social Media
Tags: 
Social media

The price of prevention: what now for immunisation against meningococcus B?

Moxon R, Snape MD. Lancet. 2013 Aug 3;382(9890):369-70.

Target: 
Decision Makers, Government and Public Health, Healthcare Professionals, Industry & Commerce
Topic: 
Epidemiology, Microbiology, Prevention, Vaccination
Tags: 
Meningococcus B, BMJ, Vaccine

Influenza: marketing vaccine by marketing disease

Doshi P. BMJ. 2013 May 16;346:f3037. 

The CDC pledges “To base all public health decisions on the highest quality scientific data, openly and objectively derived.” But Peter Doshi argues that in the case of influenza vaccinations and their marketing, this is not so.

Link to full text

Target: 
Citizens, Decision Makers, Government and Public Health, Healthcare Professionals, Industry & Commerce, School and Education
Topic: 
Vaccination
Tags: 
Marketing, Vaccine, flu, influenza, BMJ

Involving local communities: the Ebola case

Monday, May 11, 2015 - 09:39

The report published in March 2015 by Medecins sans frontières speaks out clearly against the “global coalition of inaction” and the “vacuum of leadership” in the Ebola crisis in West Africa. Those who were struggling in the field against a huge and out-of-control emergency, without the necessary resources, list the main causes of such a situation: lack of political will, inexperience, and, sometimes, simply fear.

Target: 
Citizens, Decision Makers, Government and Public Health, Healthcare Professionals, Industry & Commerce, School and Education
Topic: 
Citizens' Mobilization, Epidemiology, Human Rights, Local Activities, Policy, Stakeholders, Treatment
Tags: 
Ebola, Viewpoint

Playing with vaccines: a proposal for a new LEGO set

Monday, April 20, 2015 - 12:59

The beginning of the European Immunization Week, which will be followed in a few days by the World Immunization Week, is a perfect chance to remind the importance of vaccination and immunization programme. Among the several initiatives to keep the attention high on such a topic, one involved even the Lego group. Lego ideas is a website developed by the famous Danish toy company where fans may share ideas and proposals for new Lego set. The website allows everyone to post an idea and to gather support.

Target: 
Citizens, Industry & Commerce, School and Education
Topic: 
Citizens' Mobilization, Prevention, Vaccination
Tags: 
Vaccine

World Immunization week

Friday, April 24, 2015 (All day)

The World Immunization Week, which will be held from 24-30 April 2015, will signal a renewed global, regional, and national effort to accelerate action to increase awareness and demand for immunization by communities, and improve vaccination delivery services.

Read more
Type: 
General event
Target: 
Citizens, Decision Makers, Government and Public Health, Healthcare Professionals, Industry & Commerce, School and Education
Topic: 
Human Rights, Prevention, Vaccination
Tags: 
Event, WHO, Vaccine

ASSET High Level Policy Forum members meet for the first time

Friday, March 27, 2015 - 10:31

The first meeting of the Asset High Level Policy Forum was held in Bruxelles on March 12.  The Forum was intended to bring together selected European policy-makers at regional, national and EU levels, key decision makers in health agencies, the pharmaceutical industry, and civil society organisations, in a unique and interactive dialogue to promote on-going reflection on EU strategic priorities about pandemics.

Target: 
Citizens, Decision Makers, Government and Public Health, Healthcare Professionals, Industry & Commerce
Topic: 
Policy
Tags: 
Event

Is the elimination goal for measles threatened?

Tuesday, March 17, 2015 - 14:17

The debate over measles vaccine is underway in many countries and, in some cases, the discussion came to court. It happened, for instance, in Italy in 2012, when a judge recognized the right to compensation (required by Italian law) for the family of a child vaccinated in 2002 with the trivalent vaccine MPR (measles-mumps-rubella) who were later diagnosed with autism. During the debate, the consultant of the family presented the research of the English physician Andrew Wakefield.

Target: 
Citizens, Decision Makers, Government and Public Health, Healthcare Professionals, Industry & Commerce, School and Education
Topic: 
Vaccination
Tags: 
Vaccine, measles, WHO, Europe

Tracking influenza’s steps and targets

Monday, February 16, 2015 - 17:20

According to the last news from FluNews Europe, the current wave of influenza is causing a higher level of mortality among elderly people compared to the four previous seasons. In fact, an excess of all-cause mortality among the elderly (aged ≥65 years), concomitant with increased influenza activity and the predominance of A(H3N2) viruses, has been observed in recent weeks in Belgium, France, Portugal, Spain, Switzerland and the United Kingdom (England, Scotland and Wales).

Target: 
Citizens, Decision Makers, Government and Public Health, Healthcare Professionals, Industry & Commerce, School and Education
Topic: 
Epidemiology, Microbiology, Prevention
Tags: 
Surveillance

Pages

Subscribe to Industry & Commerce

MMLAP and other EU Projects

AsiaFluCap
Health system analysis to support capacity development in response to the threat of pandemic influenza in Asia
BEWATER
Making society an active participant in water adaptation to global change
CASI
Public Participation in Developing a Common Framework for Assessment and Management of Sustainable Innovation
CIMULACT
Engaging all of Europe in shaping a desirable and sustainable future
DARWIN
Expect the unexpected and know how to respond
DRIVER
Driving innovation in crisis management for European resilience
ECOM
Effective communication in outbreak management: development of an evidence-based tool for Europe
EDEN
Solutions to improve CBRNe resilience
EPISOUTH
Network for Communicable Disease Control in Southern Europe and Mediterranean Countries
EPIWORK
Developing the framework for an epidemic forecast infrastructure
EUPHARE
Strengthening of the national surveillance system for communicable diseases
EUROHEP
Surveillance of vaccine preventable hepatitis
EuroMOMO
European monitoring of excess mortality for public health action
EURONHID
European network for highly infectious disease
EUVAC.NET
Dedicated surveillance network for surveillance and control of vaccine preventable diseases in the EU
FLUMODCONT
Modelling the spread of pandemic influenza and strategies for its containment and mitigation
FLURESP
Cost-effectiveness assessment of european influenza human pandemic alert and response strategies
GAP2
Bridging the gap between science, stakeholders and policy makers
HProImmune
Promotion of immunization for health professionals in Europe
INPROFOOD
Towards inclusive research programming for sustainable food innovations
JA-CHRODIS
Addressing chronic diseases and healthy ageing across the life cycle
M-Eco
Medical ecosystem – personalized event-based surveillance
MAPPING
Studying the many and varied economic, social, legal and ethical aspects of the recent developments on the Internet, and their consequences for the individual and society at large
MARINA
Get involved in the responsible marine research and innovation
PACITA
Knowledge-based policy-making on issues involving science, technology and innovation, mainly based upon the practices in Parliamentary Technology Assessment
PANDEM
Assessment of the current pandemic preparedness and response tools, systems and practice at national, EU and global level in priority areas
PE2020
Analysis of innovative public engagement tools and instruments for dynamic governance in the field of Science in Society
PERARES
Public Engagement with Research And Research Engagement with Society
PHEME
Computing Veracity – the Fourth Challenge of Big Data
PREPARE
Providing infrastructure, co-ordination and integration of existing clinical research networks on epidemics and pandemics
PROMOVAX
Promote vaccinations among migrant population in Europe
R&DIALOGUE
Creating mechanisms for effectively tackling the scientific and technology related challenges faced by society
RESPIRE
Improve the quality of indoor air, keeping it free from radon
SATORI
Improving respect of ethics principles and laws in research and innovation, in line with the evolution of technologies and societal concerns
SECURING CITIES AGAINST GLOBAL PANDEMICS
Investigating how cities in the West securitise against global pandemics
SEiSMiC
Creating a structured dialogue and mutual learning with citizens and urban actors by setting up National Networks in 10 countries across Europe
SIS CATALYST
Identifying how children can be change agents in the Science and Society relationship
SYN-ENERGENE
Establishing an open dialogue between stakeholders concerning synthetic biology’s potential benefits and risks
TELLME
Transparent communication in Epidemics: Learning Lessons from experience, delivering effective Messages, providing Evidence